Evidence map›Paper›PMID 42605267›Full record

ArticleHuman vaccines & immunotherapeutics2026

"I know how important it is": A qualitative analysis of participants' experiences in a vaccine safety study.

Anila Naz AliSher, Salima Siraj, Devon Greyson, Thabisile Qwabi, Nomsa Ndaba, Nellie Myburgh, Karina A Top, International Network of Special Immunization Services (INSIS) Investigators

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anila Naz AliSherFaculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0001-8572-5390
Salima SirajFaculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.ORCID 0009-0001-3428-1934
Devon GreysonSchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.ORCID 0000-0003-4860-384X
Thabisile QwabiWits VIDA Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0002-2670-3535
Nomsa NdabaWits VIDA Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Nellie MyburghWits VIDA Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0003-2907-4591
Karina A TopDepartment of Pediatrics and School of Public Health, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-9981-368X
International Network of Special Immunization Services (INSIS) Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Specialist immunization clinics can support vaccination counseling for individuals experiencing adverse events following immunization (AEFIs) and research into AEFIs. We sought to describe the experiences of participants from the Canadian Special Immunization Clinic Network COVID-19 vaccine safety study. Qualitative interviews were conducted about participants' experiences with COVID-19 vaccination, developing an AEFI, and enrolling in a research study. Interviews were analyzed using interpretive descriptive methods guided by the socio-ecological model. Three women and five men, ages 22-59 y, were interviewed. After experiencing AEFIs, participants largely continued to trust in science and COVID-19 vaccine effectiveness, though some felt they had not been adequately informed about the potential risks of COVID-19 vaccination. They also reported hesitation from healthcare providers to attribute their symptoms to the vaccine and difficulty accessing care for their AEFI. While participants expressed a desire to assist research efforts into AEFIs, challenges included complicated consent procedures and apprehensions regarding privacy. Improving diagnosis and care of individuals with AEFIs and strengthening research efforts will require changes at organizational and policy levels, including enhanced clinician training on AEFIs and simplifying research consent processes, as well as individual and community-level interventions to tailor communication and strengthen interactions between clinicians and vaccine recipients.

Indexed as

COVID-19COVID-19 VaccinesVaccinationAdultCanadaFemaleHumansMaleMiddle AgedQualitative ResearchVaccination HesitancyYoung AdultCOVID-19 Vaccinesadverse event following immunization (AEFI)interpretive descriptionResearch participationsocio-ecological modelvaccine decision-making

Identifiers

PMID42605267
PMCPMC13483466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.